Product Categories
Country: | United States |
---|---|
Tel: | +1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | info@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36 Washington Street, Wellesley Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
WD2000-012547 | C17H14N2O | 283172-68-9 | Details |
(Rac)-WAY-161503 | C11H11Cl2N3O | 75704-24-4 | Details |
VD2-D3 | C28H44O | 1217448-46-8 | Details |
WAY127093B racemate | C23H28N4O4 | 145743-63-1 | Details |
VD3-D6;Vitamin D3-26,26,26,27,27,27-d6 | C27H38D6O | 118584-54-6 | Details |
Veledimex racemate;INXN-1001 racemate;RG-115932 racemate | C27H38N2O3 | 755013-59-3 | Details |
UbcH5c-IN-1 | C22H21BrO3 | 2123480-72-6 | Details |
UK-101 | C25H48N2O5Si | 1000313-40-5 | Details |
UK-370106 | C35H44N2O5 | 230961-21-4 | Details |
Ubiquinol;CoQH2-10;Ubiquinol-10 | C59H92O4 | 992-78-9 | Details |
Ubiquitination-IN-1 | C21H14F3N3O2S | 1819330-15-8 | Details |
UCSF924 | C20H22N2O2 | 1434515-70-4 | Details |
UK-240455 | C11H11Cl2N3O5S | 178908-09-3 | Details |
UCT943 | C22H20F3N5O | 1450666-80-4 | Details |
USP7-IN-5 | C36H43N5O6 | 2166599-74-0 | Details |
Utibapril;FPL 63547 | C22H31N3O5S | 109683-61-6 | Details |
UT-155 | C20H15F4N3O2 | 2031161-35-8 | Details |
Valategrast;R-411 free base | C30H32Cl3N3O4 | 220847-86-9 | Details |
VAF347 | C17H11ClF3N3 | 574759-62-9 | Details |
USP7-IN-6 | C41H43N7O4S | 2166586-47-4 | Details |
Valecobulin hydrochloride;CKD-516 hydrochloride | C26H29ClN6O5S | 1240321-53-2 | Details |
Valopicitabine;NM283 | C15H24N4O6 | 640281-90-9 | Details |
UT-34 | C15H12F4N4O2 | 2168525-92-4 | Details |
Valsartan-d9;CGP-48933 D9;Valsartan D9 | C24H29N5O3 | 1089736-73-1 | Details |
DL-trihexyphenidyl hydrochloride;Trihexyphenidyl HCl;Artane;Tremin | C20H32ClNO | 58947-95-8 | Details |
Vabicaserin hydrochloride;SCA 136 | C15H21ClN2 | 887258-94-8 | Details |
USP7-IN-3 | C29H31F3N6O3 | 2202738-42-7 | Details |
Nortriptyline hydrochloride;Desitriptyline HCl;EN-7048 hydrochloride;ELF-101 hydrochloride;Desmethylamitriptyline hydrochloride | C19H22ClN | 894-71-3 | Details |
Valemetostat tosylate;DS-3201 tosylate | C33H42ClN3O7S | 1809336-93-3 | Details |
Valerylcarnitine | C12H23NO4 | 40225-14-7 | Details |
Vofopitant;GR 205171 | C21H23F3N6O | 168266-90-8 | Details |
VTX-27 | C20H24ClFN6O | 1321924-70-2 | Details |
VU0650786 | C18H15ClFN5O2 | 1809085-30-0 | Details |
Seviteronel R enantiomer;VT-464 (R enantiomer) | C18H17F4N3O3 | 1375603-38-5 | Details |
AE0047 Hydrochloride | C41H43ClN4O6 | 116308-56-6 | Details |
COX/5-LO-IN-1;Atreleuton analog | C16H15FN2O2S | 154355-75-6 | Details |
CCK-B Receptor Antagonist 1 | C28H30N6O3 | 168161-71-5 | Details |
VU0364770 hydrochloride | C12H10Cl2N2O | 1414842-70-8 | Details |
VU 0365114 | C22H14F3NO3 | 1208222-39-2 | Details |
Voruciclib hydrochloride | C22H20Cl2F3NO5 | 1000023-05-1 | Details |
USP7-IN-1 | C23H24ClN3O3 | 1381291-36-6 | Details |
Vps34-IN-2 | C18H25F3N4O3 | 1523404-29-6 | Details |
SPR719;VXc-486 | C21H25FN6O3 | 1384984-18-2 | Details |
Riboflavin phosphate sodium;FMN-Na;FMN;Vitamin B2 Phosphate Sodium Salt;Riboflavin 5'-phosphate sodium;riboflavin-5'-phosphate;Flavin mononucleotide | C17H22N4NaO9P | 130-40-5 | Details |
Uridine 5'-diphosphate sodium salt | C9H12N2Na2O12P2 | 21931-53-3 | Details |
VU 6008667 | C24H17ClF2N2O2 | 2092923-21-0 | Details |
Urolithin B | C13H8O3 | 1139-83-9 | Details |
VP3.15 | C20H22N4OS | 1281681-54-6 | Details |
Vofopitant dihydrochloride;GR 205171A | C21H23F3N6O2HCl | 168266-51-1 | Details |
VUF11207 fumarate | C31H39FN2O8 | 1785665-61-3 | Details |
VU591 hydrochloride | C16H13ClN6O5 | 1315380-70-1 | Details |
VU6005649 | C16H12F5N3O | 2137047-43-7 | Details |
Usaramine N-oxide | C18H25NO7 | 117020-54-9 | Details |
VU6005806;AZN-00016130 | C17H16F3N7O2S | 2180914-37-6 | Details |
VU0134992 hydrochloride | C20H32BrClN2O2 | 1052515-91-9 | Details |
Permethrin;NRDC-143;Pounce;Transpermethrin;Ambush | C21H20Cl2O3 | 52645-53-1 | Details |
FCE 28654 | C25H35N2O7P | 169474-77-5 | Details |
VU0652835 | C16H19N3O3S | 1848252-81-2 | Details |
W146;W 146;W-146 | C16H27N2O4P | 909725-61-7 | Details |
Seviteronel racemate;VT-464 (racemate) | C18H17F4N3O3 | 1375603-36-3 | Details |
Tolazamide;U-17835 | C14H21N3O3S | 1156-19-0 | Details |
USP30 inhibitor 11 | C17H16N6O2S | 2067332-64-1 | Details |
VBY-825 | C23H29F4N3O5S | 1310340-58-9 | Details |
Verruculogen | C27H33N3O7 | 12771-72-1 | Details |
O-Phospho-L-serine;Phosphoserine;L-SOP;Dexfosfoserine;L-Serine O-phosphate | C3H8NO6P | 407-41-0 | Details |
EHP-101;VCE-?004.8 | C28H35NO3 | 1818428-24-8 | Details |
Carprofen;Imadyl;Ridamyl;Rimadyl | C15H12ClNO2 | 53716-49-7 | Details |
Verminoside | C24H28O13 | 50932-19-9 | Details |
Upamostat | C32H47N5O6S | 590368-25-5 | Details |
Tyrphostin AG1433;AG1433;SU1433 | C16H14N2O2 | 168835-90-3 | Details |
(S)-Rasagiline;TVP1022;S-PAI | C12H13N | 185517-74-2 | Details |
Vapendavir diphosphate;BTA798 diphosphate | C21H29N4O7P | 1198151-75-5 | Details |
Gentamicin sulfate;Gentamycin sulfate;SCH9724;NSC-82261 | C60H127N15O26S | 1405-41-0 | Details |
UK51656 | C22H28ClN3O6 | 88150-59-8 | Details |
Virginiamycin M1;Ostreogrycin A;Pristinamycin IIA | C28H35N3O7 | 21411-53-0 | Details |
UKI-1;UKI-1C | C32H47N5O5S | 220355-63-5 | Details |
Veliflapon;BAY X 1005;DG-031 | C23H23NO3 | 128253-31-6 | Details |
Virginiamycin S1 | C43H49N7O10 | 23152-29-6 | Details |
Viquidil hydrochloride;Quinotoxine hydrochloride | C20H25ClN2O2 | 52211-63-9 | Details |
Violanthin | C27H30O14 | 40581-17-7 | Details |
UP202-56 | C33H37N7O4 | 163838-04-8 | Details |
Verubulin hydrochloride;MPC-6827 hydrochloride | C17H17N3O.HCl | 917369-31-4 | Details |
(S)-Rasagiline mesylate;TVP1022 (mesylate);S-PAI mesylate | C13H17NO3S | 202464-88-8 | Details |
Valsartan Ethyl Ester | C26H33N5O3 | 1111177-30-0 | Details |
Vortioxetine D8;Lu AA 21004 D8 | C18H22N2S | 2140316-62-5 | Details |
Gastrin/CCK antagonist 1 | C28H32FN5O4 | 162271-52-5 | Details |
Umibecestat;CNP520 | C19H15ClF7N5O2 | 1387560-01-1 | Details |
U91356 | C13H17N3O | 152886-85-6 | Details |
Vicenin 3 | C26H28O14 | 59914-91-9 | Details |
UPF-648 sodium salt | C11H9Cl2NaO3 | 1465017-87-1 | Details |
T 82 | C30H33N3O6 | 252264-92-9 | Details |
Vatinoxan hydrochloride;MK-467 hydrochloride;L-659066 hydrochloride | C20H27ClN4O4S | 130466-38-5 | Details |
Veledimex (S enantiomer);RG-115932 S enantiome;INXN-1001 S enantiome | C27H38N2O3 | 1093131-03-3 | Details |
URAT1 inhibitor 1 | C19H15Br2N5O2S2 | 2268720-62-1 | Details |
Vapreotide acetate;RC-160 acetate;BMY-41606 acetate | C59H74N12O11S2 | 849479-74-9 | Details |
Acitretin;Etretin;Ro 10-1670 | C21H26O3 | 55079-83-9 | Details |
Vilazodone-d8;Vilazodone D8 | C26H26N5O2 | 1794789-93-7 | Details |
Vapreotide;RC160;BMY 41606 | C57H70N12O9S2 | 103222-11-3 | Details |
Viridicatol | C15H11NO3 | 14484-44-7 | Details |
UNC10217938A | C26H28N6O2 | 1347749-97-6 | Details |
Product Total: Product Page: | ||||
25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 |